Patients with resistant acute myeloid leukemia, breast cancer, and Merkel cell carcinoma had increased expression of ABCB5 mRNA after standard treatment with chemotherapeutic agents[64,75,96]. The gene discussed is ABCB5; the disease is breast carcinoma.